EYE

National Vision Holdings, Inc.

70
Fundamentals65/ 100
Valuation88/ 100
Upside potential73/ 100
Risk potential19/ 100

EYE has the edge over GME overall, supported by stronger modeled upside and lower modeled downside.

GME

GameStop Corp.

49
Fundamentals73/ 100
Valuation61/ 100
Upside potential32/ 100
Risk potential51/ 100

GME offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

EYE Fundamentals

MetricStatus
Stable
Healthy
Under pressure
Healthy

EYE's profitability and balance sheet are currently healthy, and its revenue is stable, but its cash flow is under pressure.

GME Fundamentals

MetricStatus
Stable
Strong
Strong
Unavailable

GME's profitability and cash flow are currently strong, and its revenue is stable. There isn't enough data to rate its balance sheet.

EYE PE Valuation

CHEAPFAIREXPENSIVE334x667x1001x1334x
CHEAPFAIREXPENSIVE334x667x1001x1334x
LevelPEPriceVs current
Forward16x$18.57—
Current23x$18.57—
Cheap28x$22.52+21%
Fair50x$40.68+119%
Expensive103x$83.20+348%

Historical ranges are pointers, not guarantees.

EYE has the edge over GME in the historical PE scenario, which offers more potential upside but is not a forecast.

GME PE Valuation

CHEAPFAIREXPENSIVE367x734x1101x1467x
CHEAPFAIREXPENSIVE367x734x1101x1467x
LevelPEPriceVs current
Current17x$25.62—
Cheap18x$27.96+9.1%
Forward38x$25.62—
Fair43x$66.84+161%
Expensive252x$388+1414%

Historical ranges are pointers, not guarantees.

GME's PE is in its cheap range at 17x. Analysts expect earnings to fall, which would put today's price at 38x next year's earnings, in its fair range.

EYE Forward outlook

MetricOutlook
Strongly improving
Strong growth
Stable
Improving
Limited
Moderate

EYE has the edge over GME on the outlook, with more favorable valuation and earnings expectations.

GME Forward outlook

MetricOutlook
Strongly deteriorating
Strong decline
Strong decline
Strongly weakening
Limited
High

Analysts expect GME's earnings and revenue to decline, with profitability weakening.

EYE Risk to reward

ScenarioChangePrice
Upside+52%$28.23
Downside-19%$15.04

Calculated from the latest close: $18.57 on Nov 12.

EYE has a better modeled risk to reward balance than GME, with more potential upside and less potential downside.

GME Risk to reward

ScenarioChangePrice
Upside+24%$31.72
Downside-51%$12.64

Calculated from the latest close: $25.62 on Nov 12.

GME trails EYE on modeled risk to reward, with less potential upside and more potential downside.

EYE Earnings Per Share

Q4 2023: $-0.84Q1 2024: $-0.91Q2 2024: $-1.02Q3 2024: $-0.19Q4 2024: $-0.36Q1 2025: $-0.33Q2 2025: $-0.18Q3 2025: $-0.03Q1 2026: $0.37Q2 2026: $0.57Q3 2026: $0.61Q4 2026: $0.81Forward: $1.16
Q4 2023: $-0.84Q1 2024: $-0.91Q2 2024: $-1.02Q3 2024: $-0.19Q4 2024: $-0.36Q1 2025: $-0.33Q2 2025: $-0.18Q3 2025: $-0.03Q1 2026: $0.37Q2 2026: $0.57Q3 2026: $0.61Q4 2026: $0.81Forward: $1.16
QuarterTTM EPSYoY
Forward$1.16+44%
Q3 2026$0.81+$0.84
Q2 2026$0.61+$0.79
Q1 2026$0.57+$0.90
Q4 2025$0.37+$0.73
Q3 2025-$0.03+$0.16
Q2 2025-$0.18+$0.84
Q1 2025-$0.33+$0.58
Q4 2024-$0.36+$0.48

EYE has returned to profit: it earned $0.81 per share over the past year, after losing money the year before.

GME Earnings Per Share

Q4 2023: $-0.03Q1 2024: $0.02Q2 2024: $0.08Q3 2024: $0.13Q4 2024: $0.18Q1 2025: $0.33Q2 2025: $0.53Q3 2025: $0.80Q4 2025: $0.89Q1 2026: $0.77Q2 2026: $1.34Q3 2026: $1.54Forward: $0.67
Q4 2023: $-0.03Q1 2024: $0.02Q2 2024: $0.08Q3 2024: $0.13Q4 2024: $0.18Q1 2025: $0.33Q2 2025: $0.53Q3 2025: $0.80Q4 2025: $0.89Q1 2026: $0.77Q2 2026: $1.34Q3 2026: $1.54Forward: $0.67
QuarterTTM EPSYoY
Forward$0.67-56%
Q3 2026$1.54+93%
Q2 2026$1.34+153%
Q1 2026$0.77+133%
Q4 2025$0.89+394%
Q3 2025$0.80+515%
Q2 2025$0.53+563%
Q1 2025$0.33+1550%
Q4 2024$0.18+$0.21

GME's earnings per share have climbed steadily: $1.54 over the past year, up 93% from the year before, and higher year over year for 15 quarters in a row.

EYE Quarterly Revenue

Q4 2023: $506MQ1 2024: $543MQ2 2024: $452MQ3 2024: $452MQ4 2024: $437MQ1 2025: $510MQ2 2025: $486MQ3 2025: $487MQ1 2026: $503MQ2 2026: $544MQ3 2026: $499MQ4 2026: $511M
Q4 2023: $506MQ1 2024: $543MQ2 2024: $452MQ3 2024: $452MQ4 2024: $437MQ1 2025: $510MQ2 2025: $486MQ3 2025: $487MQ1 2026: $503MQ2 2026: $544MQ3 2026: $499MQ4 2026: $511M
QuarterRevenueYoY
Q3 2026$510.5M+4.8%
Q2 2026$498.8M+2.5%
Q1 2026$543.9M+6.6%
Q4 2025$503.4M+15%
Q3 2025$487.3M+7.9%
Q2 2025$486.4M+7.7%
Q1 2025$510.3M-5.9%
Q4 2024$437.3M-14%

EYE has the edge over GME on sales, with more consistent year-over-year improvement.

GME Quarterly Revenue

Q4 2023: $1.1BQ1 2024: $1.8BQ2 2024: $882MQ3 2024: $798MQ4 2024: $860MQ1 2025: $1.3BQ2 2025: $732MQ3 2025: $972MQ4 2025: $821MQ1 2026: $1.1BQ2 2026: $835MQ3 2026: $790M
Q4 2023: $1.1BQ1 2024: $1.8BQ2 2024: $882MQ3 2024: $798MQ4 2024: $860MQ1 2025: $1.3BQ2 2025: $732MQ3 2025: $972MQ4 2025: $821MQ1 2026: $1.1BQ2 2026: $835MQ3 2026: $790M
QuarterRevenueYoY
Q3 2026$790.2M-19%
Q2 2026$835.3M+14%
Q1 2026$1.1B-14%
Q4 2025$821M-4.6%
Q3 2025$972.2M+22%
Q2 2025$732.4M-17%
Q1 2025$1.3B-28%
Q4 2024$860.3M-20%

GME's revenue has slid since its 2022 peak: $790M last quarter, down 19% from the same quarter a year ago.

EYE Free Cash Flow

Q4 2023: −$13MQ1 2024: $4MQ2 2024: $32MQ3 2024: $4MQ4 2024: −$2MQ1 2025: $12MQ2 2025: $42MQ3 2025: $30MQ1 2026: −$11MQ2 2026: $44MQ3 2026: −$14MQ4 2026: $49M
Q4 2023: −$13MQ1 2024: $4MQ2 2024: $32MQ3 2024: $4MQ4 2024: −$2MQ1 2025: $12MQ2 2025: $42MQ3 2025: $30MQ1 2026: −$11MQ2 2026: $44MQ3 2026: −$14MQ4 2026: $49M
QuarterFree cash flowYoY
Q3 2026$49.3M+63%
Q2 2026-$14.1M-133%
Q1 2026$44.1M+267%
Q4 2025-$11.2M-$9.5M
Q3 2025$30.3M+647%
Q2 2025$42.4M+33%
Q1 2025$12M+202%
Q4 2024-$1.7M+$11.3M

EYE still generates free cash flow, though less than at its 2020 peak: $68M over the past year.

GME Free Cash Flow

Q4 2023: $11MQ1 2024: −$19MQ2 2024: −$115MQ3 2024: $66MQ4 2024: $20MQ1 2025: $159MQ2 2025: $190MQ3 2025: $113MQ4 2025: $107MQ1 2026: $187MQ2 2026: $333MQ3 2026: $61M
Q4 2023: $11MQ1 2024: −$19MQ2 2024: −$115MQ3 2024: $66MQ4 2024: $20MQ1 2025: $159MQ2 2025: $190MQ3 2025: $113MQ4 2025: $107MQ1 2026: $187MQ2 2026: $333MQ3 2026: $61M
QuarterFree cash flowYoY
Q3 2026$60.7M-46%
Q2 2026$332.9M+76%
Q1 2026$187.4M+18%
Q4 2025$107M+435%
Q3 2025$113.3M+73%
Q2 2025$189.6M+$304.3M
Q1 2025$158.8M+$177.5M
Q4 2024$20M+80%

GME has the edge over EYE on cash flow, with more consistent year-over-year improvement.

EYE Total Shares

Q4 2023: 78MQ1 2024: 79MQ2 2024: 79MQ3 2024: 79MQ4 2024: 79MQ1 2025: 79MQ2 2025: 80MQ3 2025: 81MQ1 2026: 81MQ2 2026: 81MQ3 2026: 81MQ4 2026: 80M
Q4 2023: 78MQ1 2024: 79MQ2 2024: 79MQ3 2024: 79MQ4 2024: 79MQ1 2025: 79MQ2 2025: 80MQ3 2025: 81MQ1 2026: 81MQ2 2026: 81MQ3 2026: 81MQ4 2026: 80M
PeriodChange %Net change
Quarterly-0.7%-533K shares
1 year-1.4%-1.1M shares
3 years+2.4%+1.9M shares
5 years-17%-16.4M shares
Available history-2.1%-1.7M shares

EYE has the edge over GME on shareholder dilution, with a more favorable share count trend.

GME Total Shares

Q4 2023: 305MQ1 2024: 305MQ2 2024: 306MQ3 2024: 387MQ4 2024: 438MQ1 2025: 395MQ2 2025: 498MQ3 2025: 547MQ4 2025: 592MQ1 2026: 549MQ2 2026: 592MQ3 2026: 593M
Q4 2023: 305MQ1 2024: 305MQ2 2024: 306MQ3 2024: 387MQ4 2024: 438MQ1 2025: 395MQ2 2025: 498MQ3 2025: 547MQ4 2025: 592MQ1 2026: 549MQ2 2026: 592MQ3 2026: 593M
PeriodChange %Net change
Quarterly+0.1%+300K shares
1 year+8.4%+46.1M shares
3 years+94%+288M shares
5 years+104%+302M shares
Available history+80%+264M shares

GME has 593M diluted shares, up 8.4% from a year ago.

EYE Net Leverage

Q4 2023: 5.7xQ1 2024: 7.1xQ2 2024: 8.2xQ3 2024: 2.7xQ4 2024: 3.2xQ1 2025: 3.1xQ2 2025: 2.2xQ3 2025: 1.6xQ1 2026: 1.3xQ2 2026: 1.0xQ3 2026: 1.1xQ4 2026: 0.9x
Q4 2023: 5.7xQ1 2024: 7.1xQ2 2024: 8.2xQ3 2024: 2.7xQ4 2024: 3.2xQ1 2025: 3.1xQ2 2025: 2.2xQ3 2025: 1.6xQ1 2026: 1.3xQ2 2026: 1.0xQ3 2026: 1.1xQ4 2026: 0.9x
QuarterNet LeverageStatus
Q3 20260.9xVery low
Q2 20261.1xHealthy
Q1 20261.0xVery low
Q4 20251.3xHealthy
Q3 20251.6xHealthy
Q2 20252.2xModerate
Q1 20253.1xElevated
Q4 20243.2xElevated

EYE's net debt is less than a year of its operating earnings (EBITDA), down from 1.6 years a year ago.

GME Net Leverage

EYE Weekly Momentum

MetricValueStatus
RSI48.6Neutral
Stochastic33.1Neutral

EYE's weekly RSI is 49 (neutral) and its Stochastic is 33 (neutral).

GME Weekly Momentum

MetricValueStatus
RSI59.9Neutral
Stochastic68.5Neutral

GME's weekly RSI is 60 (neutral) and its Stochastic is 69 (neutral).

EYE PE vs Consumer Cyclical Sector

MetricEYESector medianRelative
PE23x18x27% above
PE %74740 pts below

EYE is trading at 23x earnings, a 27% premium to the Consumer Cyclical sector's median of 18x.

GME PE vs Consumer Cyclical Sector

MetricGMESector medianRelative
PE17x18x7.7% below
PE %154732 pts below

GME has the edge over EYE on valuation relative to its sector.

EYE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$17.47% above
20 week MA$18.40.7% above
50 week MA$22.016% below
100 week MA$20.59.5% below
200 week MA$19.75.6% below

EYE has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 5.6% below its 200-week average.

GME Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$25.21.8% above
20 week MA$22.415% above
50 week MA$22.613% above
100 week MA$24.07% above
200 week MA$21.817% above

GME has the edge over EYE on trend strength, trading above more of its moving averages.

EYE Yearly ROI

YearStart priceEnd priceROI
2020$33.1$47.3+43%
2021$47.3$47.8+1.1%
2022$47.8$38.7-19%
2023$38.7$20.9-46%
2024$20.9$10.6-49%
2025$10.6$28.0+165%
2026 YTD$28.0$18.6-34%

EYE's yearly returns have swung widely, from +165% in 2025 to −49% in 2024. It's down 34% so far in 2026.

GME Yearly ROI

YearStart priceEnd priceROI
2020$1.48$5.04+241%
2021$5.04$38.0+655%
2022$38.0$20.1-47%
2023$20.1$17.5-13%
2024$17.5$32.2+84%
2025$32.2$21.1-35%
2026 YTD$21.1$25.6+21%

GME has the edge over EYE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key